Latest Asx Listings News

Amplia Therapeutics has told ASX it is unaware of any undisclosed information that explains a sharp fall in its share price and a surge in trading volume. The response followed an ASX price query issued after the stock dropped from $0.100 to $0.079 on 16 October.

Cleanaway has told ASX it knows of no undisclosed information behind a sharp intraday share-price fall. The company said it will provide another update on EQT’s proposed takeover before trading begins on 19 October.

Vitura Health grew FY2026 revenue 6% to $131.2 million, but a sharp margin squeeze pushed the ASX-listed digital health company into a $4.4 million statutory loss. With ANZ debt classified as current and a potential $6 million FY2027 revenue hit from changed Bupa referrals, the promised turnaround faces a demanding test.

Gateway Mining will elevate Richard Pugh to managing director and install Anthony McClure as chair after its November AGM, as the company prepares to intensify exploration at Yandal. The leadership reset comes with a $340,000 fixed package for Pugh and 15 million performance rights tied to share-price hurdles.

Netwealth has pushed total funds under administration to a record $139.2 billion, with managed accounts driving a quarterly surge in funds under management. But the company has lowered FY27 net-flow guidance and flagged fresh investment in loss-making acquisition Paradino, while defending First Guardian-related class action proceedings.

Enova Mining has proposed a 50-for-1 share consolidation that would reduce its current share count from about 2.278 billion to roughly 45.552 million, subject to shareholder approval. The final post-consolidation figure could be substantially higher if its proposed funding and Brazilian acquisition securities proceed.

Infinity Metals has cut the equity consideration for its Tule Canyon acquisition option by A$10,000, reducing the maximum issue from 10 million to 9 million shares. The revised terms are designed to keep the related-party transaction below the ASX threshold requiring shareholder approval and an independent expert report.

Maronan Metals has added a new AGM resolution seeking approval for a $20 million placement to fund drilling, feasibility work and permitting at its Maronan Project. The issue would also allow Kinterra Fund II to lift its voting power to approximately 22.99%.

SIV Capital reported a $28,000 operating cash outflow for the September quarter and held $7.781 million in cash and interest-bearing deposits. The balance sheet remains substantial, but the company’s securities have now been suspended from ASX quotation since December 2024 while it evaluates a transaction.

Bougainville Copper’s half-year loss widened to K13.4 million as operating cash outflows accelerated and a one-off partner termination fee added to costs. The company also faces continuing uncertainty over its rights to the Panguna mine after its exploration licence was subordinated to a new 25-year mining lease.

Overwatch Technologies is seeking A$8 million to fund an ASX listing and expand its drone-enabled maritime intelligence business. The company has A$3.8 million of contracted orders, but has yet to recognise revenue and reported an inaugural loss of A$857,604.

Biotron has appointed Glenn Gilbert as chief executive and executive director, bringing more than two decades of pharmaceutical, medical device and diagnostics experience to the company’s SedRx and antiviral programs. His package combines a $250,000 salary with up to 100 million performance-based options and $230,000 in milestone-linked cash bonuses.